Purpose of review 

To summarize the recent developments in considering Hashimoto's thyroiditis as a risk factor for thyroid cancer.

Recent findings 

Modern approaches to understanding the co-occurrence of Hashimoto's thyroiditis and thyroid cancer have consistently found increased prevalence of both conditions, separately as well as of their coexistence. The inflammatory process in Hashimoto's thyroiditis is understood as a potential risk factor for thyroid cancer development. This has also provided a better understanding of the limitations in the current diagnostic and follow-up armamentarium for both conditions, resulting in international guidelines from the clinical and scientific societies. Other recent developments call for a paradigm shift in guidelines on thyroid carcinomas when lymphocytic infiltration is present, which potentially should always be considered the case at least in areas of sufficient iodine intake.

Summary 

The literature of Hashimoto's thyroiditis as a risk factor for thyroid cancer is reviewed over the last year to highlight new developments in the understanding of their association and future clinical implications.

中文翻译：

---

桥本甲状腺炎是甲状腺癌的危险因素

审查目的 

总结考虑桥本甲状腺炎作为甲状腺癌危险因素的最新进展。

最近的发现 

理解桥本甲状腺炎和甲状腺癌共存的现代方法一致地发现，这两种疾病的患病率以及两者的共存率都有所提高。桥本甲状腺炎的炎症过程被认为是甲状腺癌发展的潜在危险因素。这也使人们对当前的诊断和后续军备库在这两种情况下的局限性有了更好的了解，从而产生了来自临床和科学学会的国际指导方针。其他最近的进展要求当存在淋巴细胞浸润时甲状腺癌的指导方针发生范式转变，至少在碘摄入量足够的地区，应始终考虑这一点。

概要 

去年，对桥本甲状腺炎作为甲状腺癌危险因素的文献进行了综述，以突出了解其关联性和未来临床意义的新进展。